CompanyDrug

ImmuneOnco’s IMM2520 Receives FDA Clinical Trial Approval

CompanyDrug

Jiangsu Recbio’s COVID-19 Vaccine ReCOV Shows Superiority in Phase II Trial

CompanyDrug

Treadwell Therapeutics Presents PLK4 Inhibitor Data at ASH Annual Meeting

CompanyMedical Device

Cryofocus Biotechnology’s RDN System Gains FDA Breakthrough Therapy Designation

Policy / Regulatory

Beijing Releases COVID-19 Infection Drug List to Address Stocking Issues

CompanyDeals

Cutia Therapeutic Plans IPO on Hong Kong Stock Exchange

Policy / Regulatory

China’s State Council Boosts Internet Medical Services Amid COVID-19

CompanyDrug

Asieris Pharmaceuticals Enrolls First Patient in Phase II Study for APL-1202

CompanyDrug

Jiangsu Yahong Administers First Dose of Hexvix in Hainan Pilot Zone

CompanyDrug

Ascletis Pharma Announces Positive Phase I Results for ASC10 in COVID-19 Treatment

CompanyDeals

Yantai Dongcheng to Acquire US Firm XingImaging for $30.2M

CompanyMedical Device

Hotgen Biotech’s COVID-19 Antigen Home Test Approved in Russia